Work

929MO Becotatug (JMT101, Beco) combined with docetaxel (albumin-bound, HB1801) for the treatment of patients (pts) with locally advanced squamous cell non-small cell lung cancer (sqNSCLC): A randomized control phase II study (BATTLE study)

Year: 2025

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.10.635

Authors: L. Zhang, W.F. Fang, Z. Huang, S. Huang, H. Luo, H. Sun, L. Sun, W. Guo, F. Luo, P. Chen, Z. Zhang, J. Zhou, J. Hao, X. Yang, Y. Yang, Y. Su, C. Zhang, X. Wan, Y. Song, R. Zhang

Institutions: Sun Yat-sen University Cancer Center, Fujian Medical University, Fujian Provincial Cancer Hospital, First Affiliated Hospital of Zhengzhou University, Jiangxi Provincial Cancer Hospital, First Affiliated Hospital of Nanchang University, Shanxi Provincial Cancer Hospital, West China Hospital of Sichuan University, Tianjin Medical University Cancer Institute and Hospital, Linyi People's Hospital, First Affiliated Hospital Zhejiang University, CSPC Pharmaceutical Group

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7116894841

FWCI:

Cites:

Cited by:

Related to: 10